Narrative review examines biobanking's role in enhancing precision oncology through Africa's genetic diversity, suggesting crucial infrastructure improvements.
Cancer mortality in sub-Saharan Africa is projected to double by 2030. African populations exhibit the highest genetic diversity worldwide, impacting cancer susceptibility, tumor biology, and therapeutic response, yet remain critically underrepresented in biomedical research. This narrative review examines biobanking and genomic research infrastructure in sub-Saharan Africa and its implications for precision oncology, highlighting that locally governed, sustainable biobanks and equitable international partnerships are fundamental prerequisites for Precision Oncology Without Borders .
No takes yet. Share an insight, caveat, or question.
Winter et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: